Lucera Erick
SEC CIK 1697616 · EDGAR
BoughtSold
Most active insiders at DYN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rhodes Jason P | Dir | — | $129.10M |
| 2 | Kersten Dirk | Dir | — | $38.57M |
| 3 | Cox John | CEO, Pres, Dir | — | $443.7K |
| 4 | Posner Brian S | Dir | $274.8K | — |
| 5 | Kerr Douglas | Chief Medical Off | — | $233.1K |
| 6 | Lucera Erick | CFO | — | $228.7K |
| 7 | Friedl-Naderer Johanna | Chief Commercial Off | — | $43.4K |
| 8 | Lubner David Charles | Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-17 16:06 | 2026-08-13 | DYN | Dyne Therapeutics, Inc. | Lucera Erick | CFO | S - Sale | $26.28 | -1,797 | 119.8K | -1% | -$47.2K |
| 2026-06-26 16:15 | 2026-06-25 | DYN | Dyne Therapeutics, Inc. | Lucera Erick | CFO | S - Sale | $20.37 | -2,362 | 121.6K | -2% | -$48.1K | |
| T | 2026-05-14 16:03 | 2026-05-13 | DYN | Dyne Therapeutics, Inc. | Lucera Erick | CFO | S - Sale | $18.36 | -1,448 | 123.9K | -1% | -$26.6K |
| T | 2026-04-03 16:10 | 2026-04-01 | DYN | Dyne Therapeutics, Inc. | Lucera Erick | CFO | S - Sale | $18.64 | -5,727 | 125.4K | -4% | -$106.8K |
| D | 2026-02-17 | 2026-02-12 | DYN | Dyne Therapeutics, Inc. | Lucera Erick | CFO | A - Grant | $0.00 | +65.0K | 131.1K | +98% | $0 |
| D | 2025-04-01 | 2025-03-31 | DYN | Dyne Therapeutics, Inc. | Lucera Erick | CFO | A - Grant | $0.00 | +66.1K | 66.1K | New | $0 |
| 2025-03-05 | 2025-03-04 | EDIT | Editas Medicine, Inc. | Lucera Erick | EVP, CFO | S - Sale | $1.71 | -4,109 | 112.7K | -4% | -$7,026 | |
| 2024-08-15 | 2024-08-14 | XAIR | Beyond Air, Inc. | Lucera Erick | Dir | P - Purchase | $0.4 | +39.3K | 43.6K | +904% | +$15.7K | |
| 2024-05-22 | 2024-05-20 | EDIT | Editas Medicine, Inc. | Lucera Erick | EVP, CFO | S - Sale | $5.61 | -22.3K | 116.8K | -16% | -$125.3K | |
| DM | 2024-03-05 | 2024-03-02 | EDIT | Editas Medicine, Inc. | Lucera Erick | EVP, CFO | A - Grant | $0.00 | +61.3K | 139.2K | +79% | $0 |
| D | 2023-05-18 | 2023-05-17 | EDIT | Editas Medicine, Inc. | Lucera Erick | EVP, CFO | A - Grant | $0.00 | +77.9K | 77.9K | New | $0 |
| 2023-03-20 | 2023-03-16 | XAIR | Beyond Air, Inc. | Lucera Erick | Dir | P - Purchase | $6.82 | +2,000 | 4,342 | +85% | +$13.6K |
Purchase Sale Sale after option exercise All abbreviations